Loading
AI
AveXis, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Knudten Andrew F., was filed 22 Aug 2016.
AveXis, Inc.: what insiders have been doing
AveXis, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for AveXis, Inc. The previous disclosure was published on 15 May 2018.
The full history, which starts in 2016, counts 7 purchases against 133 sales.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
203
Thresholds
n/a
Buy Volume
€13M
7 ops. · all time
Sell Volume
€23M
133 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2017FY ended December 2017 · cache
Income statement
Net income-194.4M
Last declaration on 15 May 2018
Declarations203 total
2,500 sharesCommon StockSEC:0001209191-18-030118:0
8,800 sharesCommon StockSEC:0001209191-18-030121:0
3,800 sharesCommon StockSEC:0001209191-18-030117:0
1,106 sharesCommon StockSEC:0001209191-18-030120:0
11,000 sharesCommon StockSEC:0001209191-18-030127:0
2,308 shares0Common StockSEC:0001209191-18-030131:0
3,800 sharesCommon StockSEC:0001209191-18-030126:0
1,764,142 sharesCommon StockSEC:0001209191-18-030119:0
1,106 shares0Common StockSEC:0001209191-18-030133:0
1,106 shares0Common StockSEC:0001209191-18-030130:0
1,106 shares0Common StockSEC:0001209191-18-030122:0
1,035,657 shares0Common StockSEC:0001209191-18-030122:1
228,752 shares0Common StockSEC:0001209191-18-030124:0
1,201,160 shares0Common StockSEC:0001209191-18-030124:1
25,293 shares0Common StockSEC:0001209191-18-030124:2
3,800 sharesCommon StockSEC:0001209191-18-030123:0
1,106 shares0Common StockSEC:0001209191-18-030132:0
1,667 shares0Common StockSEC:0001209191-18-030129:0
2,836 shares@ US$117.002.8% of flowCommon StockSEC:0001209191-18-023749:0
2,007 shares@ US$118.172.0% of flowCommon StockSEC:0001209191-18-023749:1
4,021 shares@ US$119.294.1% of flowCommon StockSEC:0001209191-18-023749:2
3,179 shares@ US$120.183.2% of flowCommon StockSEC:0001209191-18-023749:3
929 shares@ US$121.641.0% of flowCommon StockSEC:0001209191-18-023749:4
1,182 shares@ US$122.291.2% of flowCommon StockSEC:0001209191-18-023749:5
25 of 203 declarations
About AveXis, Inc.
AveXis, Inc. is a biopharmaceutical company focused on developing gene therapies for rare neurological diseases. It is listed on NASDAQ under the symbol AVXS.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
